Dihexa
- 99%+ HPLC Purity — Independently verified by accredited US laboratory
- Endotoxin-Screened — LAL tested, LPS-free, endotoxin report available
- GMP-Certified Manufacturing — USA facility, ISO 9001:2015
- Lyophilized for Stability — Shipped cold-packed, intact for reconstitution
Add essential supplies:
For laboratory research use only. Not for human or veterinary use.
About Dihexa
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic oligopeptide derived from angiotensin IV. It is supplied here as a lyophilized powder at 99%+ HPLC purity for laboratory research use only.
This material is a research chemical. It is not a medicine, is not for human or veterinary use, and no dosing, administration or handling-in-humans guidance is provided.
What is Dihexa?
Dihexa is a small-molecule angiotensin IV analog originally developed in academic neuroscience research. Its reported mechanism involves the hepatocyte growth factor (HGF) / c-Met pathway.
- HGF/c-Met research target: published assays describe binding to HGF and activation of the c-Met receptor in cell models.
- Small-molecule profile: its low molecular weight is frequently cited in blood-brain-barrier permeability studies in animal models.
- Synaptogenesis assays: used as a reference compound in in-vitro studies of synaptic connection formation.
Published research context
The following summarises third-party in-vitro and animal-model literature. These are laboratory observations only, not human outcomes, and nothing here describes a therapeutic effect.
Cognitive models
Rodent studies have reported changes in memory-task performance in scopolamine-impairment and aging models.
Potency comparisons
Published work compares Dihexa's in-vitro activity with brain-derived neurotrophic factor in synaptogenesis assays.
Neuroprotection assays
Cell-culture studies have measured neuronal survival under induced oxidative stress.
Peripheral nerve models
Animal-model research has examined HGF/c-Met pathway activity in nerve-repair assays.
Why researchers select this material
Laboratory handling characteristics reported for this compound:
- Well-defined small-molecule structure suitable for analytical verification.
- Established presence in published neuroscience literature for protocol comparison.
- Supplied at 99%+ HPLC purity with published batch documentation.
- Stable lyophilized format under recommended cold storage.
Frequently Asked Questions
Dihexa: specification and research context
Dihexa is a synthetic angiotensin IV–derived oligopeptide, CAS 1401708-83-5, molecular formula C₂₅H₄₁N₃O₄ at 451.6 g/mol. It is supplied as a lyophilized powder in a 10mg vial at 99%+ purity; additional mg options and multi-vial tier pricing are selectable above and reflected in the displayed price.
Dihexa is studied in preclinical neuroscience literature for its interaction with the hepatocyte growth factor / c-Met pathway and its activity in synaptogenesis assays. These are laboratory and animal-model observations reported by researchers; they are not demonstrated human outcomes.
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any condition.
- Strength: 10mg vial (additional mg options available)
- Purity: 99%+ HPLC · Reference LPDIH-01
- CAS 1401708-83-5 · C₂₅H₄₁N₃O₄ · 451.6 g/mol
- Form: lyophilized powder — research use only
Review the matching batch documentation in our HPLC testing library, compare strengths across the independently tested research peptide catalog, or ask about volume pricing on the bulk offers page.
